Fibromyalgia ME CFS Australia Bridges & Pathways

Fibromyalgia ME CFS Australia Bridges & Pathways We work collaboratively to fasttrack change. All Australians have the right to best practice medical care. On this page we share useful information and research.

Bridges & Pathways Institute/ Fibromyalgia Australia is an Australian charity working towards solutions, services/research for all Australians living with poorly understood complex chronic condtions. Bridges & Pathways/Fibromyalgia Australia works in partnerships to improve daily care, early diagnosis and management of Fibromyalgia and ME/CFS in primary care settings We particularly focus on consumer priorities and improving health outcomes by fast tracking research into affordable daily care. We facilitate provider training, clinical research, with best practice resources and case assessments and management. Australians urgently need immediate access affordable multidisciplinary management to limit their condition and improve quality of life. Just because there is not cure does not mean nothing can be done to improve, health, wellbeing and quality of life. There is a let of emerging research that give us hope.

🌼Calling all friends in the ME/CFS Fibromyalgia Community🌼👀We look to you to help us shed greater light on the research ...
26/03/2026

🌼Calling all friends in the ME/CFS Fibromyalgia Community🌼
👀We look to you to help us shed greater light on the research being conducted to help bring practical solutions to those living with ME/CFS and Fibromyalgia.
By participating in this short anonymous survey you can illuminate the path for future support and success. We encourage you to please complete share 🤗
https://www.facebook.com/share/p/1E4AU8sjHY/

🌼Calling all friends in the ME/CFS Fibromyalgia Community🌼

👀We look to you to help us shed greater light on the research being conducted to help bring practical solutions to those living with ME/CFS and Fibromyalgia.

By participating in this short anonymous survey you can illuminate the path for future support and success. We encourage you to please complete share 🤗

SURVEY LINK BELOW
https://us9.list-manage.com/survey?u=d9d73f15014c129d77c6a531c&id=036abcf7c0&attribution=false

23/03/2026
21/03/2026

In this article, we have made a comprehensive overview of research findings on the immuneContinue readingThe immune system in ME/CFS

19/03/2026

Not long ago, the nervous and immune systems were considered largely independent. That understanding has shifted significantly.

In the March newsletter, Associate Professor Gila Moalem-Taylor writes about the emerging science of neuroimmune crosstalk in chronic pain, and what it could mean for how we treat conditions like Complex Regional Pain Syndrome.

A/Professor Moalem-Taylor will deliver the Bonica Lecture ‘Decoding the neuroimmune axis: Pathways to novel immunotherapies for neuropathic pain’ at APS 2026 on Wednesday 22 April.

🔗 Read the full article in the March newsletter: https://www.apsoc.org.au/Newsletter-JAN-MAR26

—

APS 2026 Annual Scientific Meeting
Connect with the pain community. Strengthen your clinical practice.

📍 Adelaide Convention Centre
📅 19–22 April 2026
🔗 Register: dccam.com.au/aps2026

the translational research process diagram - we are well on the way!!! Join our working groups, share your priorities?...
19/03/2026

the translational research process diagram - we are well on the way!!! Join our working groups, share your priorities??

Here is the requested diagram - South Australia is indeed a leader in Translational Research that fast tracks research into real life changes for patient groups - we continue to support Australian researchers ...

13/03/2026
11/03/2026

🧬Science Wednesdays: Estimating Lifetime Prevalence of

Prevalence is the number of people that have a disease currently.

Lifetime prevalence is similar, but is a measurement of how many people will ever experience a disease in their lifetime.

🌐 Based on published research, the lifetime prevalence of ME/CFS is over 279 million people, which is around 1 in 29.

🔗 Read more about lifetime prevalence of ME/CFS: https://ow.ly/NW5s50Ysr5S

03/03/2026

A recent article in the International Journal of Environmental Research and Public Health highlights how everyday clinical phrases can unintentionally harm patients with Long COVID, ME/CFS, dysautonomia, and other complex chronic conditions.

When tests are normal and treatments are limited, words matter even more.

The paper outlines “never-words” or common phrases that can unintentionally damage the therapeutic relationship, and offers alternatives that strengthen trust and collaboration.

Read more: https://www.mdpi.com/1660-4601/22/2/275

08/12/2025

From October 22 through October 25, I attended the 2025 IACFSME 17th Research and Clinical Conference (International Association for Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis)…

Address

Adelaide
Adelaide, SA
5000

Website

Alerts

Be the first to know and let us send you an email when Fibromyalgia ME CFS Australia Bridges & Pathways posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Our Story

It is time for change! Bridges & Pathways Institute Inc. works to fast track best practice services for the one million Australians affected by ME/CFS (Myalgic Encephalomyelitis / Chronic Fatigue Syndrome) and Fibromyalgia. Our current priority is to extend General Practice Clinical Care and Research and to train and equip more Australian health providers through improving clinical resources and precision based medical care.